Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-55 of 55 for

Edit search filters
  1. The Establishment of an Allogeneic Cartilage Bank for the Center for Regenerative Medicine

    Rochester, MN

  2. Allogeneic Mesenchymal Stromal Cell Donor Bank

    Rochester, MN

  3. A Study to Learn More About the Chemicals Produced by Cells Involved in Liver Regeneration (regrowth) After Living Liver Donation

    Rochester, MN

  4. Development of Skeletal Muscle Fibers from Patient-Derived Induced Pluripotent Stem Cells (iPSCs)

    Rochester, MN

  5. A Study to Assess and Compare Regenerative Injection Therapies such as Bone Marrow Aspiration and Concentration (BMAC) and Platelet Rich Plasma (PRP) for Osteoarthritis

    Jacksonville, FL

.

Mayo Clinic Footer